Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Pancreatic Cancer
Patients in Tampa General Hospital’s Pancreatic Oncology Program have access to the latest breakthroughs in pancreatic cancer treatment, including hyperthermic intraperitoneal chemotherapy (HIPEC).
What is HIPEC?
HIPEC is a progressive form of chemotherapy that can be used to help treat pancreatic cancer and other hepatobiliary malignancies that have spread to the abdominal cavity. Chemotherapy is a type of drug that is given to attack cancer cells in a specific area or throughout the body.
HIPEC for pancreatic cancer is usually performed alongside surgery to remove visible cancers that remain after the primary tumor is resected. During HIPEC, the cancer-fighting drug is heated to increase potency and delivered directly into the abdominal cavity. Because it is administered during surgery, surgeons are able to ensure the chemotherapy is applied to the most affected areas.
Although HIPEC is a relatively new treatment approach for pancreatic cancer, it is producing positive results and improving outcomes for some patients. HIPEC is also associated with fewer and less severe side effects than traditional chemotherapies.
Our Approach to Pancreatic Cancer Treatment
At TGH, we know that multiple therapies are better than one. That’s why our multispecialty team of pancreatic cancer experts collaborate to design diverse and carefully crafted treatment plans for patients. In addition to HIPEC, TGH provides the latest advancements in radiation therapy, robotic-assisted procedures, resection surgery, radiofrequency ablation and several other approaches.
To learn more about HIPEC and pancreatic cancer treatment at TGH, contact us at (813) 844-2200. We welcome patients who are seeking second opinions and prioritize prompt response times.